Literature DB >> 27682210

Differential expression of systemic inflammatory mediators in amputees with chronic residual limb pain.

Alexander Chamessian1, Thomas Van de Ven2,3, Thomas Buchheit2,3, Hung-Lun Hsia2,3, Mary McDuffie4, Eric R Gamazon5, Colin Walsh6,7, Stephen Bruehl8, Chester 'Trip' Buckenmaier4,9, Andrew Shaw8.   

Abstract

Chronic postsurgical pain impacts most amputees, with more than half experiencing neuralgic residual limb pain. The transition from normal acute postamputation pain to chronic residual limb pain likely involves both peripheral and central inflammatory mechanisms. As part of the Veterans Integrated Pain Evaluation Research study, we investigated links between systemic inflammatory mediator levels and chronic residual limb pain. Subjects included 36 recent active duty military traumatic amputees with chronic residual limb pain and 40 without clinically significant pain. Blood samples were obtained and plasma concentrations of an array of inflammatory mediators were analyzed. Residual limb pain intensity and pain catastrophizing were assessed to examine associations with inflammatory mediators. Pro-inflammatory mediators including tumor necrosis factor (TNF)-α, TNF-β, interleukin (IL)-8, ICAM-1, Tie2, CRP, and SAA were elevated in patients with chronic residual limb pain. Across all patients, residual limb pain intensity was associated positively with levels of several proinflammatory mediators (IL-8, TNF-α, IL-12, TNF-β, PIGF, Tie2, SAA, and ICAM-1), and inversely with concentrations of the anti-inflammatory mediator IL-13, as well as IL-2 and Eotaxin-3. Pain catastrophizing correlated positively with IL-8, IL-12, TNF-β, PIGF, and ICAM-1, and inversely with IL-13. Significant associations between catastrophizing and residual limb pain intensity were partially mediated by TNF-α, TNF- β, SAA, and ICAM-1 levels. Results suggest that chronic postamputation residual limb pain is associated with excessive inflammatory response to injury or to inadequate resolution of the postinjury inflammatory state. Impact of pain catastrophizing on residual limb pain may be because of part to common underlying inflammatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27682210      PMCID: PMC5161626          DOI: 10.1097/j.pain.0000000000000728

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  33 in total

Review 1.  The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines.

Authors:  Paul J Austin; Gila Moalem-Taylor
Journal:  J Neuroimmunol       Date:  2010-09-25       Impact factor: 3.478

2.  SPSS and SAS procedures for estimating indirect effects in simple mediation models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods Instrum Comput       Date:  2004-11

Review 3.  Persistent postsurgical pain: risk factors and prevention.

Authors:  Henrik Kehlet; Troels S Jensen; Clifford J Woolf
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

4.  Cytokine-mediated inflammatory hyperalgesia limited by interleukin-13.

Authors:  B B Lorenzetti; S Poole; F H Veiga; F Q Cunha; S H Ferreira
Journal:  Eur Cytokine Netw       Date:  2001 Apr-Jun       Impact factor: 2.737

Review 5.  The role of the immune system in the generation of neuropathic pain.

Authors:  Margarita Calvo; John M Dawes; David L H Bennett
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

6.  Chronic pain, body mass index and cardiovascular disease risk factors: tests of moderation, unique and shared relationships in the Study of Women's Health Across the Nation (SWAN).

Authors:  John W Burns; Phillip J Quartana; Stephen Bruehl; Imke Janssen; Sheila A Dugan; Bradley Appelhans; Karen A Matthews; Howard M Kravitz
Journal:  J Behav Med       Date:  2014-11-27

Review 7.  Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain.

Authors:  Maurice Theunissen; Madelon L Peters; Julie Bruce; Hans-Fritz Gramke; Marco A Marcus
Journal:  Clin J Pain       Date:  2012 Nov-Dec       Impact factor: 3.442

8.  Differential expression patterns of cytokines in complex regional pain syndrome.

Authors:  Nurcan Uçeyler; Tatiana Eberle; Roman Rolke; Frank Birklein; Claudia Sommer
Journal:  Pain       Date:  2007-09-24       Impact factor: 6.961

9.  Differential expression of cytokines in painful and painless neuropathies.

Authors:  Nurcan Uçeyler; Jan P Rogausch; Klaus V Toyka; Claudia Sommer
Journal:  Neurology       Date:  2007-07-03       Impact factor: 9.910

Review 10.  Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

Authors:  Christian A von Hehn; Ralf Baron; Clifford J Woolf
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

View more
  5 in total

Review 1.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

2.  Carapanosins A-C from Seeds of Andiroba (Carapa guianensis, Meliaceae) and Their Effects on LPS-Activated NO Production.

Authors:  Keiichiro Higuchi; Teppei Miyake; Shoko Ohmori; Yoshimi Tani; Katsuhiko Minoura; Takashi Kikuchi; Takeshi Yamada; Reiko Tanaka
Journal:  Molecules       Date:  2017-03-22       Impact factor: 4.411

3.  CD8+ T cell-derived IL-13 increases macrophage IL-10 to resolve neuropathic pain.

Authors:  Susmita K Singh; Karen Krukowski; Geoffroy O Laumet; Drew Weis; Jenolyn F Alexander; Cobi J Heijnen; Annemieke Kavelaars
Journal:  JCI Insight       Date:  2022-03-08

Review 4.  Postoperative pain pathophysiology and treatment strategies after CRS + HIPEC for peritoneal cancer.

Authors:  Xiao Wang; Tianzuo Li
Journal:  World J Surg Oncol       Date:  2020-03-31       Impact factor: 2.754

5.  Systemic inflammatory markers in neuropathic pain, nerve injury, and recovery.

Authors:  Oliver Sandy-Hindmarch; David L Bennett; Akira Wiberg; Dominic Furniss; Georgios Baskozos; Annina B Schmid
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.